Trilogy Capital’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Buy
3,349
+180
+6% +$15.6K 0.01% 363
2026
Q2
$294K Sell
3,169
-72
-2% -$6.7K 0.01% 334
2026
Q1
$315K Sell
3,241
-269
-8% -$24.6K 0.01% 313
2025
Q4
$310K Sell
3,510
-30
-0.8% -$2.73K 0.01% 308
2025
Q3
$319K Buy
3,540
+75
+2% +$6.07K 0.01% 302
2025
Q2
$263K Buy
3,465
+600
+21% +$44.6K 0.01% 314
2025
Q1
$204K Buy
+2,865
New +$223K 0.01% 326

Other funds holding SRE

Trilogy Capital's SRE Position: Q3 2026 in Review

Trilogy Capital increased its Sempra (SRE) stake by 5.7% in Q3 2026, buying an estimated $15.6K and bringing the position to 3,349 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #363.

Trilogy Capital first reported a position in SRE in Q1 2025 and has held it in 7 quarters since. The position peaked at $319K in Q3 2025. 294 funds tracked by Wall St. Rank hold SRE as of Q3 2026.

  • Trilogy Capital held 3,349 shares of Sempra worth $261K as of Q3 2026.
  • Trilogy Capital bought 180 Sempra shares in Q3 2026, an estimated $15.6K.
  • Sempra made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #363 holding.
  • Trilogy Capital first reported a position in Sempra in Q1 2025 and has held it in 7 quarters since.
  • Trilogy Capital's Sempra position peaked at $319K in Q3 2025.
  • 294 funds tracked by Wall St. Rank held Sempra as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.